LATIGO BIOTHERAPEUTICS
Operator of a drug discovery company intended to develop novel, non-opioid therapies for chronic pain. The company utilizes unique, translated insights to provide a differentiated approach to targeting therapeutics across the blood-nerve barrier, enabling patients to get access to a pain management therapy that does not create addiction, dependence or tolerability.
LATIGO BIOTHERAPEUTICS
Founded:
2018-01-01
Total Employee:
1+
Status:
Active
Total Funding:
15 M USD
Similar Organizations
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
Teligene
Teligene is a drug discovery company edicating to developing innovative small-molecule drugs.
Current Employees Featured
Scott Wasserman
Scott Wasserman Chief Executive Officer @ Latigo Biotherapeutics Chief Executive Officer 2019-05-01
Investors List
Corner Ventures
Corner Ventures investment in Funding Round - Latigo Biotherapeutics